12,184.2077.3
Stock Analysis, IPO, Mutual Funds, Bonds & More

Will new FSSAI rules undercut baby food law?

Ostensibly to deal with three very rare medical conditions in infants, FSSAI decided to exempt several products from the IMS Act.

Updated: Mar 06, 2018, 11.24 AM IST
0Comments
Others
FSSAI-web
FSSAI's other argument is that products under the IMS Act can be taken on the advice of a health worker, while these special diets need medical supervision.
(This story originally appeared in on Mar 06, 2018)
Does special infant food for certain rare medical conditions have to be kept out of the Infant Milk Substitute (IMS) Act — a law to prevent predatory marketing practices by baby food companies — to ensure their availability? This question sparked a tussle between public health activists and the Food Safety and Standards Authority of India (FSSAI).

Ostensibly to deal with three very rare medical conditions in infants, FSSAI decided to exempt several products from the IMS Act. Baby food companies used this to sponsor doctors and market these special foods, which the IMS Act prohibits. Following protests from health activists, FSSAI clarified that the Act's provisions on marketing, promotion and sponsorship would apply to these special foods, but they would otherwise remain out of its ambit.

The Act is hailed globally as one of the most effective laws to protect breastfeeding against unethical marketing by baby-food companies. As a result, the sale of baby food formula in India is a tiny fraction of that in China, which does not have a similar stringent law.

So why is FSSAI keeping these special foods out of the Act? FSSAI says that since the Act says all baby food labels have to carry a statement "mother's milk is best for your baby" in capital letters, special foods for inborn metabolic errors have to be kept out of the legislation. However, according to the WHO and the American Academy of Paediatrics (AAP), there are only three inborn metabolic diseases in which breastfeeding can harm the baby. Of these, AAP says breastfeeding is an absolute no-no in just one, galactosemia. In the other two, phenylketonuria and maple syrup urine disease, breastfeeding is allowed along with special formula under medical monitoring.

FSSAI's other argument is that products under the IMS Act can be taken on the advice of a health worker, while these special diets need medical supervision.

The problem is that FSSAI has exempted all foods for special medical purposes (FSMPs). FSMPs include formulas for low birth-weight babies, hypoallergenic formulas for babies with cow milk allergy and lactose free formulas. These are already sold in India, regulated by the IMS and FSSAI Acts. They have labels saying that mother's milk is best, an advisory that they are to be used under medical supervision and a label clearly identifying them as infant milk substitutes.

Even before the draft regulation of exemption to these products got approved, FSSAI okayed labels of many of these special foods with a sticker, "This is neither an infant milk substitute nor an infant food". This is the key concern, pointed out Dr Arun Gupta of the Breastfeeding Promotion Network of India, one of four bodies responsible for reporting IMS Act violations. "Will violations under IMS Act attract penalties when the products are being kept out of its purview? The exemption will only create confusion that baby-food companies will take advantage of. The policy to exempt some baby foods from IMS Act is flawed and is the result of partnership with baby food companies," he charged.

Also Read

PM Modi's proposers: Whistleblower on baby food and Dom Raja

Railways to provide baby food at stations

Nestle looking into complaint of live beetles in baby food

Live worms found in Nestle Cerelac baby food in Coimbatore

Comments
Add Your Comments
Commenting feature is disabled in your country/region.

Other useful Links


Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service